Escitalopram
Escitalopram is a pharmaceutical drug with 293 clinical trials. Currently 18 active trials ongoing. Historical success rate of 86.0%.
Success Metrics
Based on 196 completed trials
Phase Distribution
Phase Distribution
17
Early Stage
34
Mid Stage
175
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.1%
196 of 233 finished
15.9%
37 ended early
18
trials recruiting
293
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children
Clinical Trials (293)
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children
Acupuncture and Escitalopram for Treating Major Depression Clinical Study
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
Escitalopram and the Risk of Serious Adverse Events
Escitalopram in Asthma Patients With Frequent Exacerbation
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
Efficacy and Safety of Probiotics for Anxiety Depression
Escitalopram to Placebo in Patients With Localized Pancreatic Cancer
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Impact of Escitalopram on Sperm DNA Fragmentation
The Effect of SSRIs on Threat of Shock Potentiated Neural Circuitry
Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression.
Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder
Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression
Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 293